EUVIMEDEUVIMED entdecken
Crossref

Characterization, cell toxicity, and antimicrobial activity of a carvacrol-encapsulating nanoliposomal system against Staphylococcus aureus, Pseudomonas aeruginosa, and Escherichia coli

Ali Majidi Yazdi, Arshad Hosseini, Seyed Mohammad Gheibihayat, Mohammad Beygi, Bibi Fatemeh Haghiralsadat, Fatemeh Oroojalian

Nanomedicine Journal · 2024-01 · 11 (1) · 93-106

DOI: 10.22038/nmj.2023.76136.1854 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nanomedicine Journal, 2024-01. Verfasst von Ali Majidi Yazdi und 5 weiteren Autor:innen.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective(s): Staphylococcus aureus, Pseudomonas aeruginosa, and Escherichia coli are the main pathogenic bacteria involved in severe, polymicrobial, and multidrug-resistant infections. For these infections to be overcome, lipid-based nanoparticles and nanoformulations such as liposomes have demonstrated marked potential in fighting bacterial infections by delivering antibacterial drugs, fusing with bacterial membranes, and promoting the direct delivery of antibacterial agents to bacteria. This study assesses the antibacterial effects of various formulations of carvacrol (CV)-encapsulating nanoliposomes on S. aureus, P. aeruginosa, and E. coli. The study further evaluates the cytotoxicity of the fabricated nanoliposomal system against human foreskin fibroblast (HFF) cells.Materials and Methods: Various formulations of the liposomal nanosystem were first prepared through the thin film hydration method utilizing different concentrations of soy phosphatidylcholine (SPC), cholesterol (Chol), and Tween 60. The formulations were then evaluated for drug entrapment efficiency and release profiles, and the optimum formulation was determined for the experiments. The optimum formulation was then structurally analyzed, and the cytotoxicity of free CV and encapsulated CV on both bacteria and HFF cells was evaluated.

Results

Microbial tests revealed that CV-LPs outperform free CV regarding their antibacterial effects on the studied bacterial strains, with the maximum inhibitory effect exerted on S. aureus, followed by E. coli and P. aeruginosa.

Conclusion

Furthermore, the MTT assay indicated that the cytotoxicity of CV against normal HFF cells was remarkably declined when it was encapsulated in the liposomal nanosystem.

Schlagwörter

antimicrobial effectcarvacrolinfectionliposomesphytochemicals

Zitieren

APA

Yazdi, A. M., Hosseini, A., Gheibihayat, S. M., Beygi, M., Haghiralsadat, B. F., & Oroojalian, F. (2024). Characterization, cell toxicity, and antimicrobial activity of a carvacrol-encapsulating nanoliposomal system against Staphylococcus aureus, Pseudomonas aeruginosa, and Escherichia coli. Nanomedicine Journal, 11(1), 93-106. https://doi.org/10.22038/nmj.2023.76136.1854

Vancouver

Yazdi AM, Hosseini A, Gheibihayat SM, Beygi M, Haghiralsadat BF, Oroojalian F. Characterization, cell toxicity, and antimicrobial activity of a carvacrol-encapsulating nanoliposomal system against Staphylococcus aureus, Pseudomonas aeruginosa, and Escherichia coli. Nanomedicine Journal. 2024;11(1):93-106. doi:10.22038/nmj.2023.76136.1854

BibTeX
@article{Yazdi2024,
  author = {Yazdi, Ali Majidi and Hosseini, Arshad and Gheibihayat, Seyed Mohammad and Beygi, Mohammad and Haghiralsadat, Bibi Fatemeh and Oroojalian, Fatemeh},
  title = {Characterization, cell toxicity, and antimicrobial activity of a carvacrol-encapsulating nanoliposomal system against Staphylococcus aureus, Pseudomonas aeruginosa, and Escherichia coli},
  journal = {Nanomedicine Journal},
  year = {2024},
  volume = {11},
  number = {1},
  pages = {93--106},
  doi = {10.22038/nmj.2023.76136.1854}
}
Kostenlos starten →